Aspen’s investigational cell therapy program for Parkinson’s disease. Under the terms of the agreement, Aspen will integrate Mytos’ iDEM automated cell technology into its 22,000-square ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback